The patients with ET and NAFLD had higher WC (p=0.001), total cholesterol (p=0.042), triglycerides (p<0.001), fasting insulin (p<0.001) and HOMA-IR (p=0.001) levels compared to the subjects with ET without NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.